Heartflow (NASDAQ:HTFL) Stock Sees Unusually High Put Option Buying

Heartflow logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Put-option activity surged: Investors bought 6,628 Heartflow puts on Friday, 558% above the typical volume of 1,008. The stock rose 3.6% to $46.25 during the session.
  • Heartflow reported a quarterly loss of $0.03 per share, narrower than analysts’ expected $0.18 loss, on revenue of $72.86 million. Analysts’ consensus rating was “Moderate Buy,” with an average price target of $60.12.
  • Company insiders sold 323,936 shares worth about $16.4 million over the past 90 days; the reported transactions were conducted under pre-arranged Rule 10b5-1 plans.
  • MarketBeat previews top five stocks to own in December.

Heartflow, Inc. (NASDAQ:HTFL - Get Free Report) saw unusually large options trading activity on Friday. Investors purchased 6,628 put options on the stock. This represents an increase of 558% compared to the typical volume of 1,008 put options.

Heartflow Stock Up 3.6%

Heartflow stock traded up $1.62 during trading hours on Friday, reaching $46.25. 462,869 shares of the company's stock were exchanged, compared to its average volume of 1,610,075. The firm's 50 day simple moving average is $51.82 and its 200 day simple moving average is $35.55. Heartflow has a twelve month low of $20.13 and a twelve month high of $60.65. The firm has a market capitalization of $4.06 billion, a PE ratio of -50.26 and a beta of 2.50.

Heartflow (NASDAQ:HTFL - Get Free Report) last issued its quarterly earnings results on Thursday, November 12th. The company reported ($0.03) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.18) by $0.15. The firm had revenue of $72.86 million for the quarter. Heartflow had a negative return on equity of 20.53% and a negative net margin of 33.11%. During the same period last year, the firm posted ($0.27) earnings per share. Analysts anticipate that Heartflow will post -0.75 EPS for the current year.

Wall Street Analysts Forecast Growth

Several equities analysts have issued reports on HTFL shares. Wall Street Zen upgraded shares of Heartflow from a "hold" rating to a "buy" rating in a research report on Sunday, November 15th. Morgan Stanley boosted their price objective on shares of Heartflow from $35.00 to $40.00 and gave the stock an "equal weight" rating in a research note on Friday, August 14th. JPMorgan Chase & Co. raised their target price on Heartflow from $35.00 to $45.00 and gave the stock an "overweight" rating in a research report on Friday, August 14th. Stifel Nicolaus lifted their target price on Heartflow from $45.00 to $70.00 and gave the stock a "buy" rating in a report on Friday, November 13th. Finally, Benchmark reissued a "buy" rating on shares of Heartflow in a research note on Friday, August 14th. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, Heartflow has an average rating of "Moderate Buy" and a consensus price target of $60.12.

Read Our Latest Analysis on Heartflow

Trending Headlines about Heartflow

Here are a few of the latest headlines about HTFL:

  • Positive Sentiment: Heartflow’s latest reported quarter showed a narrower-than-expected loss: EPS was negative $0.03 versus analysts’ expected negative $0.18, on revenue of $72.86 million. Analysts’ average rating was reported as “Moderate Buy,” with an average price target of $60.12. These are supportive context, though not new developments from today. Heartflow stock report
  • Negative Sentiment: Insider Campbell Rogers’ reported sales include 16,918 shares at an average $24.40, as well as additional sales reported in October and November. Repeated selling can weigh on investor sentiment, although the transactions were conducted under a pre-arranged Rule 10b5-1 plan. Heartflow insider sale report

Insider Transactions at Heartflow

In related news, CFO Vikram Verghese sold 29,714 shares of the business's stock in a transaction on Friday, September 11th. The stock was sold at an average price of $50.06, for a total transaction of $1,487,482.84. Following the sale, the chief financial officer owned 184,789 shares in the company, valued at $9,250,537.34. The trade was a 13.85% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Campbell Rogers sold 24,188 shares of the company's stock in a transaction dated Tuesday, November 17th. The stock was sold at an average price of $46.39, for a total value of $1,122,081.32. Following the completion of the transaction, the insider directly owned 64,424 shares of the company's stock, valued at approximately $2,988,629.36. The trade was a 27.30% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 323,936 shares of company stock worth $16,355,191. Corporate insiders own 7.70% of the company's stock.

Hedge Funds Weigh In On Heartflow

A number of large investors have recently modified their holdings of the company. XXEC Inc. bought a new stake in shares of Heartflow during the 2nd quarter worth $2,524,764,000. Quantinno Capital Management LP bought a new stake in Heartflow during the 1st quarter worth approximately $1,734,000. Sei Investments Co. boosted its stake in Heartflow by 342.5% during the first quarter. Sei Investments Co. now owns 67,048 shares of the company's stock valued at $1,631,000 after buying an additional 51,895 shares during the period. Bank of New York Mellon Corp purchased a new position in Heartflow in the 2nd quarter worth approximately $19,096,000. Finally, Handelsbanken Fonder AB bought a new position in shares of Heartflow during the 2nd quarter valued at about $910,000.

Heartflow Company Profile

(Get Free Report)

HeartFlow, Inc. is a medical technology company that develops noninvasive tools to help clinicians assess coronary artery disease. Its platform analyzes coronary CT angiography scans to create personalized models of a patient's coronary arteries and provide information that can support diagnosis and treatment planning. The company's offerings include HeartFlow FFR CT Analysis, which estimates blood flow and the effects of artery narrowing, and tools for assessing coronary plaque. The technology combines medical imaging with computational analysis and artificial intelligence, giving clinicians information without requiring an invasive procedure to measure blood flow.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Heartflow Right Now?

Before you consider Heartflow, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Heartflow wasn't on the list.

While Heartflow currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 7 Best High-Yield Dividend Stocks for 2027 Cover

Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines